New safety in the use and pancreatic cancer vaccine-induced immune response
Baltimore, Johns Hopkins Medical Association's Dr. Elizabeth M. Jaffee and his colleagues on the 14 cases eight weeks before the trip Pancreatoduodenectomy pancreatic adenocarcinoma patients given various doses of allogeneic secreted GM-CSF (granulocyte-macrophage colony-stimulating factor) of the tumor vaccine Test.
12 cases of patients tested with the vaccine after a six-month adjuvant radiotherapy and chemotherapy. Such treatment after six cases in remission after one month by month by month to give three times the original dose immunization.
More...PROSTATE CANCER: prostate cancer Knowledge Base, cases, jaffee, patients, study, tumor, vaccine